Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
China flag China · Delayed Price · Currency is CNY
16.14
+0.38 (2.41%)
At close: Feb 6, 2026

SHA:600521 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
8,6569,4958,2498,1836,6036,456
Other Revenue
52.8752.8759.5482.5640.9529.5
8,7099,5478,3098,2666,6446,485
Revenue Growth (YoY)
-6.85%14.91%0.52%24.42%2.44%20.36%
Cost of Revenue
3,4863,7383,3763,1802,6712,385
Gross Profit
5,2225,8094,9335,0863,9734,100
Selling, General & Admin
3,2353,1432,5922,5342,4482,080
Research & Development
1,129986.69982.99925.53942.26565.7
Other Operating Expenses
39.8818.415.693.6365.2150.13
Operating Expenses
4,4264,1853,5723,5083,4702,725
Operating Income
796.761,6251,3601,578502.481,375
Interest Expense
-226.73-219.8-231.69-220.02-166.34-135.33
Interest & Investment Income
44.4653.2239.4825.83180.6119.57
Currency Exchange Gain (Loss)
76.976.960.1208.94-50.99-145.37
Other Non Operating Income (Expenses)
-19.35-5.8-5.14-3.91-4.32-3.86
EBT Excluding Unusual Items
672.041,5291,2231,589461.441,110
Impairment of Goodwill
---6.46---
Gain (Loss) on Sale of Investments
35.15-98.21-162.9-70299.8126.09
Gain (Loss) on Sale of Assets
-0.392.33-0.29-16.1-9.5919.15
Asset Writedown
-65.85-30.13-32.95-2-0.16-13.58
Other Unusual Items
60.5560.5579.928.2335.4273.68
Pretax Income
701.51,4641,1001,509786.931,215
Income Tax Expense
257.36356.15283.07332.89306.28220.76
Earnings From Continuing Operations
444.151,107817.251,176480.64994.6
Minority Interest in Earnings
23.9211.5213.22-8.256.89-64.78
Net Income
468.071,119830.471,168487.54929.82
Net Income to Common
468.071,119830.471,168487.54929.82
Net Income Growth
-58.95%34.74%-28.88%139.52%-47.57%63.24%
Shares Outstanding (Basic)
1,4571,4491,4571,4421,4341,453
Shares Outstanding (Diluted)
1,4571,4491,4571,4601,4341,453
Shares Change (YoY)
-0.47%-0.52%-0.19%1.80%-1.30%4.58%
EPS (Basic)
0.320.770.570.810.340.64
EPS (Diluted)
0.320.770.570.800.340.64
EPS Growth
-59.02%35.09%-28.75%135.29%-46.88%56.10%
Free Cash Flow
-956.22319.33624.63-1,074-1,496278.97
Free Cash Flow Per Share
-0.660.220.43-0.73-1.040.19
Dividend Per Share
0.2500.2500.2000.2400.1000.200
Dividend Growth
25.00%25.00%-16.67%140.00%-50.00%10.01%
Gross Margin
59.97%60.85%59.37%61.53%59.80%63.23%
Operating Margin
9.15%17.02%16.37%19.09%7.56%21.20%
Profit Margin
5.38%11.72%9.99%14.13%7.34%14.34%
Free Cash Flow Margin
-10.98%3.35%7.52%-12.99%-22.52%4.30%
EBITDA
1,7612,5102,1412,2301,0501,846
EBITDA Margin
20.23%26.29%25.76%26.98%15.81%28.46%
D&A For EBITDA
964.71885.71780.37652.55547.8470.83
EBIT
796.761,6251,3601,578502.481,375
EBIT Margin
9.15%17.02%16.37%19.09%7.56%21.20%
Effective Tax Rate
36.69%24.33%25.73%22.06%38.92%18.16%
Revenue as Reported
8,7099,5478,3098,2666,6446,485
Advertising Expenses
-1,4171,0361,034999.39783.51
Source: S&P Global Market Intelligence. Standard template. Financial Sources.